1 completed, 1 recruiting, 1 unknown. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Ascites Hepatic: new trials by email Literature Review of Ascites Hepatic trials Research Report on Ascites Hepatic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| "Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial" Dapagliflozin - Ascites Hepatic | Phase 2 / Phase 3 | Recruiting | Beni-Suef University | 52 | 2026-07-01 | 2026-07-06 |
| Empagliflozin as a Novel Therapy in Refractory Ascites Empagliflozin 10 MG, Diuretics - Ascites Hepatic | Phase 2 / Phase 3 | Completed | Alexandria University | 42 | 2022-04-21 | 2022-11-29 |
| The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy Terlipressin plus standard care, Standard care - Terlipressin Adverse Reaction, Ascites Hepatic | Phase 3 | Unknown | Shanghai Zhongshan Hospital | 86 | 2019-11-07 | 2020-01-09 |
Acute Kidney Injury (1) · Liver Failure (1)
Digestive System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Hepatic Insufficiency (1) · Kidney Diseases (1) · Liver Diseases (1) · Male Urogenital Diseases (1) · Renal Insufficiency (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Diuretics (1) · Standard of Care (1) · Terlipressin (1) · dapagliflozin (1) · empagliflozin (1)
Alexandria University (1) · Beni-Suef University (1) · Shanghai Zhongshan Hospital (1)
Egypt (2) · China (1)